Gerald T Proehl - Net Worth and Insider Trading
Gerald T Proehl Net Worth
The estimated net worth of Gerald T Proehl is at least $12 Million dollars as of 2024-06-04. Gerald T Proehl is the President, CEO and Chairman, 10% Owner of Dermata Therapeutics Inc and owns about 3,180,465 shares of Dermata Therapeutics Inc (DRMA) stock worth over $12 Million. Gerald T Proehl is the Director of Ritter Pharmaceuticals Inc and owns about 200 shares of Ritter Pharmaceuticals Inc (RTTR) stock worth over $90. Gerald T Proehl is also the Director of Tenax Therapeutics Inc and owns about 1 shares of Tenax Therapeutics Inc (TENX) stock worth over $4. Details can be seen in Gerald T Proehl's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Gerald T Proehl has not made any transactions after 2021-11-23 and currently still holds the listed stock(s).
Transaction Summary of Gerald T Proehl
Gerald T Proehl Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Gerald T Proehl owns 5 companies in total, including Tenax Therapeutics Inc (TENX) , Sophiris Bio Inc (SPHS) , and Ritter Pharmaceuticals Inc (RTTR) among others .
Click here to see the complete history of Gerald T Proehl’s form 4 insider trades.
Insider Ownership Summary of Gerald T Proehl
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| TENX | Tenax Therapeutics Inc | 2016-11-23 | director |
| SPHS | Sophiris Bio Inc | 2019-06-27 | director |
| RTTR | Ritter Pharmaceuticals Inc | 2018-01-23 | director |
 | | 2015-06-24 | director |
| | 2021-11-23 | 10 percent owner & Pres. & CEO and Chairman |
Gerald T Proehl Latest Holdings Summary
Gerald T Proehl currently owns a total of 3 stocks. Among these stocks, Gerald T Proehl owns 3,180,465 shares of Dermata Therapeutics Inc (DRMA) as of November 23, 2021, with a value of $12 Million and a weighting of 100%. Gerald T Proehl owns 200 shares of Ritter Pharmaceuticals Inc (RTTR) as of June 24, 2015, with a value of $90 and a weighting of 0%. Gerald T Proehl also owns 1 shares of Tenax Therapeutics Inc (TENX) as of November 23, 2016, with a value of $4 and a weighting of 0%.
Latest Holdings of Gerald T Proehl
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| DRMA | Dermata Therapeutics Inc | 2021-11-23 | 3,180,465 | 3.84 | 12,212,668 |
| RTTR | Ritter Pharmaceuticals Inc | 2015-06-24 | 200 | 0.45 | 90 |
| TENX | Tenax Therapeutics Inc | 2016-11-23 | 1 | 3.51 | 4 |
Holding Weightings of Gerald T Proehl
Gerald T Proehl Form 4 Trading Tracker
According to the SEC Form 4 filings, Gerald T Proehl has made a total of 2 transactions in Dermata Therapeutics Inc (DRMA) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Dermata Therapeutics Inc is the acquisition of 20,000 shares on November 23, 2021, which cost Gerald T Proehl around $48,000.
According to the SEC Form 4 filings, Gerald T Proehl has made a total of 0 transactions in Ritter Pharmaceuticals Inc (RTTR) over the past 5 years. The most-recent trade in Ritter Pharmaceuticals Inc is the acquisition of 200 shares on June 24, 2015, which cost Gerald T Proehl around $250,000.
According to the SEC Form 4 filings, Gerald T Proehl has made a total of 0 transactions in Tenax Therapeutics Inc (TENX) over the past 5 years. The most-recent trade in Tenax Therapeutics Inc is the acquisition of 1 shares on November 23, 2016, which cost Gerald T Proehl around $49,903.
Insider Trading History of Gerald T Proehl
- 1
Gerald T Proehl Trading Performance
GuruFocus tracks the stock performance after each of Gerald T Proehl's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Gerald T Proehl is -38.75%. GuruFocus also compares Gerald T Proehl's trading performance to market benchmark return within the same time period. The performance of stocks bought by Gerald T Proehl within 3 months outperforms 0 times out of 4 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Gerald T Proehl's insider trading performs compared to the benchmark.
Performance of Gerald T Proehl
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -6.85 | | | | | |
| Relative Return to S&P 500(%) | -7.28 | | | | | |
Gerald T Proehl Ownership Network
Gerald T Proehl Owned Company Details
What does Tenax Therapeutics Inc do?
Who are the key executives at Tenax Therapeutics Inc?
Gerald T Proehl is the director of Tenax Therapeutics Inc. Other key executives at Tenax Therapeutics Inc include Interim CFO Eliot M Lurier , director & CEO Chrisopher Thomas Giordano , and Chief Medical Officer Stuart Rich .
Tenax Therapeutics Inc (TENX) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Tenax Therapeutics Inc (TENX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Tenax Therapeutics Inc (TENX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Tenax Therapeutics Inc (TENX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Tenax Therapeutics Inc Insider Transactions
Gerald T Proehl Mailing Address
Above is the net worth, insider trading, and ownership report for Gerald T Proehl. Currently GuruFocus does not have mailing address information for Gerald T Proehl.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
